MESQUITE, Nevada, Sept. 10, 2025 (GLOBE NEWSWIRE) —
September 10, 2025 – Mesquite, Nevada – Dogecoin Cash, Inc. (Ticker: $CBDS), a publicly traded entity pioneering advancements in blockchain tech, today announced its fully-owned subsidiary, PrestoDoctor, a leading provider of telemedicine services focused on medical cannabis assessments, has started accepting cryptocurrency payments for its services. This new payment option encompasses a variety of digital currencies, with a special emphasis on Dogecoin (DOGE), the namesake digital asset of Dogecoin Cash, Inc. This decision is a key element of Dogecoin Cash, Inc.’s overarching strategy to embrace decentralized technologies and provide patients with a more versatile and cutting-edge healthcare experience. “As the utilization of digital assets continues to expand, we are excited to offer our patients the ease of paying with cryptocurrency,” stated David Tobias, Chief Executive Officer of Dogecoin Cash, Inc. “By integrating Dogecoin and other prominent cryptocurrencies, PrestoDoctor is taking a significant stride towards aligning with the evolving preferences of our patient base.”
The cryptocurrencies now accepted include:
- Bitcoin (BTC)
- Ethereum (ETH)
- USD Coin (USDC)
- Tron (TRX)
- Tether (USDT)
- BNB (Binance Coin)
- Dogecoin (DOGE)
- Litecoin (LTC)
- Monero (XMR)
- Polygon (MATIC)
- Bitcoin Cash (BCH)
- Shiba Inu (SHIB)
- Solana (SOL)
- DAI
By incorporating these digital currencies, PrestoDoctor seeks to enhance the accessibility of medical cannabis evaluations for a wider, more technologically inclined patient demographic, particularly those already involved in blockchain-based financial systems.
Traditional payment methods, including credit and debit cards, will remain available to ensure that all patients can select the payment method that best suits their individual requirements.
“Implementing crypto payments is more than just about convenience; it’s about proactive adaptation and offering elevated privacy to our patients,” added Kyle Powers, CEO. “We are confident that this move will position PrestoDoctor to better accommodate the evolving dynamics of both the healthcare and digital finance sectors.”
About Dogecoin Cash, Inc.
Dogecoin Cash, Inc. (OTCQB: DOGP) is a publicly listed entity focusing on the development of blockchain innovations and their practical applications across healthcare, finance, and consumer-facing services. Through its PrestoDoctor subsidiary, the Company delivers telehealth solutions for individuals seeking medical cannabis evaluations in various states across the U.S.
For further details regarding Dogecoin Cash, Inc., please visit www.dogecoincash.com
About PrestoDoctor
PrestoDoctor is a recognized leader in the realm of online medical cannabis evaluations, providing secure, HIPAA-compliant telehealth services connecting patients with licensed doctors in a convenient and private manner.
For additional information, please visit https://prestodoctor.com/resources/crypto
Forward-Looking Statements
Certain statements included within this news release might be considered “forward-looking statements.” These types of statements represent current expectations regarding future events, based on particular assumptions, and encompass any statement lacking a direct relation to historical or present facts. Actual outcomes may significantly deviate from those expressed in these forward-looking statements due to various important factors, which may be outlined in the Company’s official filings. In addition to these elements, real-world future performance, results, and outcomes may significantly differ due to more common factors, including (but not limited to) general industry conditions, market trends, economic circumstances, and alterations in governmental and public policy. The forward-looking statements presented in this news release represent the Company’s viewpoints as of this release date, which may evolve. Although the Company may choose to revise these statements in the future, it specifically disclaims any obligation to do so. As such, these statements should not be considered representative of the Company’s views beyond the current date. These types of statements are subject to risks detailed on the company’s website and in its filings. This press release includes these statements involving uncertainties. Actual results can vary substantially from expectations. For a comprehensive discussion regarding risks, please consult the filings submitted by Dogecoin Cash, Inc. to the SEC.
